Oppenheimer Hld Financials
This page shows Oppenheimer Hld (OPY) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Oppenheimer’s results show a balance-sheet-driven earnings model where cash conversion and margins swing sharply with operating conditions.
FY2025 brought back earnings-to-cash alignment: operating cash flow recovered to$188.8M from-$108.2M in FY2024. At the same time, net margin expanded to9.1% from5.0% , suggesting the prior year's cash strain was not simply an accounting illusion but a weaker operating backdrop that later normalized.
Revenue reached
The balance sheet still does a lot of the work. Return on assets was
Financial Health Signals
Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of Oppenheimer Hld's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Oppenheimer Hld has an operating margin of 12.9%, meaning the company retains $13 of operating profit per $100 of revenue. This results in a moderate score of 43/100, indicating healthy but not exceptional operating efficiency. This is up from 7.4% the prior year.
Oppenheimer Hld's revenue grew 14.4% year-over-year to $1.6B, a solid pace of expansion. This earns a growth score of 58/100.
Oppenheimer Hld has a moderate D/E ratio of 2.77. This balance of debt and equity financing earns a leverage score of 46/100.
Oppenheimer Hld has a free cash flow margin of 11.2%, earning a moderate score of 32/100. The company generates positive cash flow after capital investments, but with room for improvement.
Oppenheimer Hld's ROE of 15.1% shows moderate profitability relative to equity, earning a score of 35/100. This is up from 8.4% the prior year.
Oppenheimer Hld passes 5 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.
For every $1 of reported earnings, Oppenheimer Hld generates $1.27 in operating cash flow ($188.8M OCF vs $148.4M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Oppenheimer Hld earns $2.4 in operating income for every $1 of interest expense ($211.2M vs $86.6M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.
Key Financial Metrics
Earnings & Revenue
Oppenheimer Hld generated $1.6B in revenue in fiscal year 2025. This represents an increase of 14.4% from the prior year.
Oppenheimer Hld's EBITDA was $222.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 90.6% from the prior year.
Oppenheimer Hld reported $148.4M in net income in fiscal year 2025. This represents an increase of 107.4% from the prior year.
Oppenheimer Hld earned $13.04 per diluted share (EPS) in fiscal year 2025. This represents an increase of 104.7% from the prior year.
Cash & Balance Sheet
Oppenheimer Hld generated $183.6M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 262.0% from the prior year.
Oppenheimer Hld held $38.4M in cash against $0 in long-term debt as of fiscal year 2025.
Oppenheimer Hld paid $1.72 per share in dividends in fiscal year 2025. This represents an increase of 160.6% from the prior year.
Margins & Returns
Oppenheimer Hld's operating margin was 12.9% in fiscal year 2025, reflecting core business profitability. This is up 5.5 percentage points from the prior year.
Oppenheimer Hld's net profit margin was 9.1% in fiscal year 2025, showing the share of revenue converted to profit. This is up 4.1 percentage points from the prior year.
Oppenheimer Hld's ROE was 15.1% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 6.7 percentage points from the prior year.
Capital Allocation
Oppenheimer Hld spent $3.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 69.0% from the prior year.
Oppenheimer Hld invested $5.2M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 0.9% from the prior year.
OPY Income Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $445.1M-5.8% | $472.6M+11.4% | $424.4M+13.7% | $373.2M+1.5% | $367.8M-2.0% | $375.4M+0.6% | $373.4M+12.9% | $330.6M |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $296.0M+13.8% | $260.1M-10.4% | $290.2M+21.4% | $239.1M+5.3% | $227.1M-11.4% | $256.4M+7.8% | $237.9M+7.8% | $220.7M |
| Operating Income | -$27.0M-125.5% | $106.0M+235.0% | $31.6M-1.8% | $32.2M-22.2% | $41.4M+142.4% | $17.1M-51.7% | $35.4M+122.9% | $15.9M |
| Interest Expense | $18.7M-7.2% | $20.1M-10.5% | $22.5M-0.1% | $22.5M+5.3% | $21.4M+0.2% | $21.4M-11.4% | $24.1M+9.7% | $22.0M |
| Income Tax | -$6.4M-120.1% | $32.1M+223.0% | $9.9M-5.8% | $10.5M-1.7% | $10.7M+69.2% | $6.3M-41.6% | $10.9M+94.0% | $5.6M |
| Net Income | -$20.6M-127.7% | $74.4M+242.5% | $21.7M+0.2% | $21.7M-29.3% | $30.7M+185.7% | $10.7M-56.2% | $24.5M+138.7% | $10.3M |
| EPS (Diluted) | $-1.93 | N/A | $1.90-0.5% | $1.91-29.8% | $2.72 | N/A | $2.16+134.8% | $0.92 |
OPY Balance Sheet
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.8B+2.5% | $3.7B-2.5% | $3.8B+3.5% | $3.7B+3.2% | $3.6B+5.6% | $3.4B+0.5% | $3.4B+3.2% | $3.3B |
| Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $34.6M-9.9% | $38.4M+0.3% | $38.3M+1.8% | $37.6M+2.5% | $36.7M+10.7% | $33.1M+2.8% | $32.2M-2.9% | $33.2M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | $143.6M0.0% | $143.6M0.0% | $143.6M0.0% | $143.6M0.0% | $143.6M0.0% | $143.6M+1.0% | $142.2M0.0% | $142.2M |
| Total Liabilities | $2.8B+4.6% | $2.7B-6.0% | $2.9B+3.8% | $2.8B+3.4% | $2.7B+6.6% | $2.5B+0.1% | $2.5B+3.2% | $2.5B |
| Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | $0-100.0% | $112.8M0.0% | $112.8M |
| Total Equity | $952.4M-3.2% | $983.8M+6.9% | $920.3M+2.6% | $896.9M+2.8% | $872.3M+2.6% | $850.4M+1.5% | $837.8M+3.2% | $812.1M |
| Retained Earnings | $924.9M-2.4% | $947.4M+6.7% | $887.7M+2.3% | $867.9M+2.3% | $848.7M+3.5% | $820.0M+1.1% | $811.1M+2.8% | $788.7M |
OPY Cash Flow Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$190.0M-207.3% | $177.0M+179.1% | $63.4M+58.3% | $40.1M+143.7% | -$91.7M-222.8% | $74.7M+553.4% | $11.4M+109.9% | -$115.3M |
| Capital Expenditures | $0-100.0% | $1.2M-2.2% | $1.2M+7.0% | $1.1M-33.0% | $1.7M-48.5% | $3.3M+1382.3% | $220K-84.4% | $1.4M |
| Free Cash Flow | -$190.0M-208.1% | $175.8M+182.6% | $62.2M+59.8% | $38.9M+141.7% | -$93.4M-230.7% | $71.5M+537.2% | $11.2M+109.6% | -$116.7M |
| Investing Cash Flow | $549K+171.3% | -$770K-220.1% | $641K+171.2% | -$900K-150.7% | -$359K+91.6% | -$4.3M-329.6% | $1.9M+261.6% | -$1.2M |
| Financing Cash Flow | $185.6M+205.4% | -$176.1M-177.8% | -$63.4M-65.7% | -$38.2M-140.0% | $95.6M+237.6% | -$69.5M-386.9% | -$14.3M-111.7% | $122.0M |
| Dividends Paid | $12.4M+555.8% | $1.9M-0.1% | $1.9M+0.1% | $1.9M-0.1% | $1.9M+1.9% | $1.9M0.0% | $1.9M+20.1% | $1.5M |
| Share Buybacks | $0-100.0% | $2.3M | $0-100.0% | $581K+545.6% | $90K | $0-100.0% | $294K-68.2% | $925K |
OPY Financial Ratios
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | -6.1%-28.5pp | 22.4%+15.0pp | 7.4%-1.2pp | 8.6%-2.6pp | 11.3%+6.7pp | 4.5%-4.9pp | 9.5%+4.7pp | 4.8% |
| Net Margin | -4.6%-20.3pp | 15.7%+10.6pp | 5.1%-0.7pp | 5.8%-2.5pp | 8.3%+5.5pp | 2.9%-3.7pp | 6.6%+3.5pp | 3.1% |
| Return on Equity | -2.2%-9.7pp | 7.6%+5.2pp | 2.4%-0.1pp | 2.4%-1.1pp | 3.5%+2.3pp | 1.3%-1.7pp | 2.9%+1.7pp | 1.3% |
| Return on Assets | -0.5%-2.5pp | 2.0%+1.4pp | 0.6%-0.0pp | 0.6%-0.3pp | 0.9%+0.5pp | 0.3%-0.4pp | 0.7%+0.4pp | 0.3% |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt-to-Equity | 2.99+0.2 | 2.77-0.4 | 3.15+0.0 | 3.11+0.0 | 3.10+3.1 | 0.00-0.1 | 0.130.0 | 0.14 |
| FCF Margin | -42.7%-79.9pp | 37.2%+22.5pp | 14.7%+4.2pp | 10.4%+35.8pp | -25.4%-44.4pp | 19.0%+16.0pp | 3.0%+38.3pp | -35.3% |
Similar Companies
Frequently Asked Questions
What is Oppenheimer Hld's annual revenue?
Oppenheimer Hld (OPY) reported $1.6B in total revenue for fiscal year 2025. This represents a 14.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Oppenheimer Hld's revenue growing?
Oppenheimer Hld (OPY) revenue grew by 14.4% year-over-year, from $1.4B to $1.6B in fiscal year 2025.
Is Oppenheimer Hld profitable?
Yes, Oppenheimer Hld (OPY) reported a net income of $148.4M in fiscal year 2025, with a net profit margin of 9.1%.
What is Oppenheimer Hld's EBITDA?
Oppenheimer Hld (OPY) had EBITDA of $222.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Oppenheimer Hld's operating margin?
Oppenheimer Hld (OPY) had an operating margin of 12.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Oppenheimer Hld's net profit margin?
Oppenheimer Hld (OPY) had a net profit margin of 9.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Does Oppenheimer Hld pay dividends?
Yes, Oppenheimer Hld (OPY) paid $1.72 per share in dividends during fiscal year 2025.
What is Oppenheimer Hld's return on equity (ROE)?
Oppenheimer Hld (OPY) has a return on equity of 15.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Oppenheimer Hld's free cash flow?
Oppenheimer Hld (OPY) generated $183.6M in free cash flow during fiscal year 2025. This represents a 262.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Oppenheimer Hld's operating cash flow?
Oppenheimer Hld (OPY) generated $188.8M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Oppenheimer Hld's total assets?
Oppenheimer Hld (OPY) had $3.7B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Oppenheimer Hld's capital expenditures?
Oppenheimer Hld (OPY) invested $5.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Oppenheimer Hld's debt-to-equity ratio?
Oppenheimer Hld (OPY) had a debt-to-equity ratio of 2.77 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Oppenheimer Hld's return on assets (ROA)?
Oppenheimer Hld (OPY) had a return on assets of 4.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Oppenheimer Hld's Piotroski F-Score?
Oppenheimer Hld (OPY) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Oppenheimer Hld's earnings high quality?
Oppenheimer Hld (OPY) has an earnings quality ratio of 1.27x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Oppenheimer Hld cover its interest payments?
Oppenheimer Hld (OPY) has an interest coverage ratio of 2.4x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Oppenheimer Hld?
Oppenheimer Hld (OPY) scores 36 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.